Literature DB >> 10382937

Will modern cancer vaccines reach clinical practice?

G Masucci1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10382937     DOI： 10.1007/bf02787353

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  9 in total

Review 1.  Development of cancer immunotherapies based on identification of the genes encoding cancer regression antigens.

Authors:  S A Rosenberg
Journal:  J Natl Cancer Inst       Date:  1996-11-20       Impact factor: 13.506

Review 2.  Active specific T-cell-based immunotherapy for cancer: nucleic acids, peptides, whole native proteins, recombinant viruses, with dendritic cell adjuvants or whole tumor cell-based vaccines. Principles and future prospects.

Authors:  N Fernandez; M T Duffour; M Perricaudet; M T Lotze; T Tursz; L Zitvogel
Journal:  Cytokines Cell Mol Ther       Date:  1998-03

Review 3.  Immunotherapy of cancer with dendritic-cell-based vaccines.

Authors:  E Gilboa; S K Nair; H K Lyerly
Journal:  Cancer Immunol Immunother       Date:  1998-04       Impact factor: 6.968

4.  Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1.

Authors:  M Marchand; N van Baren; P Weynants; V Brichard; B Dréno; M H Tessier; E Rankin; G Parmiani; F Arienti; Y Humblet; A Bourlond; R Vanwijck; D Liénard; M Beauduin; P Y Dietrich; V Russo; J Kerger; G Masucci; E Jäger; J De Greve; J Atzpodien; F Brasseur; P G Coulie; P van der Bruggen; T Boon
Journal:  Int J Cancer       Date:  1999-01-18       Impact factor: 7.396

5.  Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma.

Authors:  S A Rosenberg; J C Yang; D J Schwartzentruber; P Hwu; F M Marincola; S L Topalian; N P Restifo; M E Dudley; S L Schwarz; P J Spiess; J R Wunderlich; M R Parkhurst; Y Kawakami; C A Seipp; J H Einhorn; D E White
Journal:  Nat Med       Date:  1998-03       Impact factor: 53.440

Review 6.  Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity.

Authors:  R M Zinkernagel; S Ehl; P Aichele; S Oehen; T Kündig; H Hengartner
Journal:  Immunol Rev       Date:  1997-04       Impact factor: 12.988

Review 7.  Gene transfer as cancer therapy.

Authors:  G Dranoff; R C Mulligan
Journal:  Adv Immunol       Date:  1995       Impact factor: 3.543

Review 8.  Tolerance, danger, and the extended family.

Authors:  P Matzinger
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

9.  Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells.

Authors:  F O Nestle; S Alijagic; M Gilliet; Y Sun; S Grabbe; R Dummer; G Burg; D Schadendorf
Journal:  Nat Med       Date:  1998-03       Impact factor: 53.440
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.